Yahoo

Is It Too Late To Consider IperionX (ASX:IPX) After Its Recent Share Price Surge?

Trade IPX on Coinbase

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.

  • If you are wondering whether IperionX is priced for its potential or already fully valued, starting with the numbers can help frame that question clearly.

  • The stock recently closed at A$4.18, with returns of 23.7% over 30 days, 17.1% over 1 year and a very large gain over 3 years, although the year to date return of 27.8% decline and a 1.4% decline over the last week show that the ride has not been smooth.

  • Recent coverage has focused on IperionX as an emerging player in materials and metals, with attention on its projects and positioning in its sector. This helps explain why the share price has seen strong multi year gains. At the same time, investors are weighing execution risks and funding needs, which helps put the recent short term pullback in context.

  • Despite that share price history, IperionX currently scores 0 out of 6 on Simply Wall St's valuation checks, as shown by the valuation score. The next sections will break down how different valuation methods assess the stock and then look at a more complete way to think about value beyond a single score.

IperionX scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown .

Approach 1: IperionX Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects a company's future cash flows and then discounts those projections back to today using a required rate of return to estimate what the business might be worth right now.

For IperionX, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is a loss of $55.29 million, and analyst and extrapolated estimates show cash flows ranging from a projected loss of $76.65 million in 2026 to positive $61.88 million in 2035, with $15.77 million forecast for 2028. Simply Wall St converts these yearly figures into today's dollars, resulting in an estimated intrinsic value of $2.63 per share.

Compared with the recent share price of A$4.18, the DCF output implies the stock is around 59.2% above this estimate, so on this model IperionX screens as expensive rather than cheap right now.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests IperionX may be overvalued by 59.2%. Discover 9 high quality undervalued stocks or create your own screener to find better value opportunities.

IPX Discounted Cash Flow as at Apr 2026
IPX Discounted Cash Flow as at Apr 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for IperionX.

Approach 2: IperionX Price vs Book Value

For companies where earnings and cash flows are still developing, price to book, or P/B, is often more useful than P/E because it anchors value to the balance sheet rather than current profitability. Investors typically expect higher P/B ratios when they see stronger growth potential or lower perceived risk, and lower P/B ratios when there are more execution or funding uncertainties.

IperionX currently trades on a P/B of 9.38x. That stands well above the Metals and Mining industry average P/B of 2.02x and also above the peer group average of 7.40x. On simple comparisons, the shares are priced at a premium to both the sector and peers.

Simply Wall St's Fair Ratio is designed to add more context by estimating what a reasonable P/B might be after considering factors such as earnings growth expectations, profit margins, market cap, risk profile and industry. This can be more informative than a straight peer comparison because it adjusts for company specific features rather than treating all miners as alike. In this case, the Fair Ratio is not available, so it is not possible to say whether 9.38x is high, low or about in line with what that model would suggest.

Result: OVERVALUED

ASX:IPX P/B Ratio as at Apr 2026
ASX:IPX P/B Ratio as at Apr 2026

P/B ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 4 top founder-led companies .

Upgrade Your Decision Making: Choose your IperionX Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so this is where Narratives come in as a simple way for you to tell the story behind your numbers for IperionX, linking your view of its projects, revenues, earnings and margins to a financial forecast and then to a fair value estimate that you can compare directly with the current share price.

On Simply Wall St's Community page, Narratives are available as an accessible tool used by millions of investors. They allow you to set your own assumptions, see the fair value that flows from those inputs, and then decide whether the gap between that fair value and today's price suggests IperionX is closer to a buy, a hold or a sell for you.

Narratives also update automatically when fresh information such as news or earnings is added to the platform. This helps your story and fair value view on IperionX stay aligned with the latest data instead of becoming stale.

For example, one IperionX Narrative might assume conservative revenue growth and modest margins that support a lower fair value. Another might assume stronger adoption of its materials and metals projects that supports a higher fair value, giving you a clear sense of where your own view fits on that spectrum.

Do you think there's more to the story for IperionX? Head over to our Community to see what others are saying!

ASX:IPX 1-Year Stock Price Chart
ASX:IPX 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include IPX.AX .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: